| 3001 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T452 | ECGA000452 | 1.99 |
| 3002 | Bicarbonate (mean, inv-norm transformed) | GCST90475148 | 1.99 |
| 3003 | Left-hemisphere salience/ventral attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302714 | 1.99 |
| 3004 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36 | ECGA000036 | 1.99 |
| 3005 | IDP dMRI ProbtrackX FA atr r | GCST90003928 | 1.99 |
| 3006 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62 | ECGA000062 | 1.98 |
| 3007 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T306 | ECGA000306 | 1.98 |
| 3008 | CLEC4D/HGF ratio | GCST90314110 | 1.98 |
| 3009 | Lymphoid leukemia, chronic (PheCode 204.12) | GCST90475613 | 1.98 |
| 3010 | Acetoacetate levels | GCST90092804 | 1.98 |
| 3011 | IDP dMRI TBSS MD Posterior thalamic radiation R | GCST90004055 | 1.98 |
| 3012 | BA-exvivo rh area MT | GCST90003232 | 1.98 |
| 3013 | TBC1D5 levels | GCST90470811 | 1.97 |
| 3014 | CA1/TGM2 ratio | GCST90313575 | 1.97 |
| 3015 | IDP dMRI TBSS OD Superior corona radiata L | GCST90004427 | 1.97 |
| 3016 | AmygNuclei rh volume Medial-nucleus | GCST90002663 | 1.97 |
| 3017 | CA1/CA2 ratio | GCST90313571 | 1.97 |
| 3018 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 1.97 |
| 3019 | Congestive heart failure | GCST90475200 | 1.97 |
| 3020 | IL1RL1 levels | GCST90241581 | 1.97 |
| 3021 | Atrial fibrillation | GCST006414 | 1.97 |
| 3022 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 1.97 |
| 3023 | Vascular dementia (subcortical) | FING00001420 | 1.97 |
| 3024 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87) | GCST90320906 | 1.96 |
| 3025 | APRT/PSME1 ratio | GCST90313338 | 1.96 |
| 3026 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T305 | ECGA000305 | 1.96 |
| 3027 | IDP dMRI TBSS ISOVF Posterior thalamic radiation L | GCST90004506 | 1.96 |
| 3028 | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | GCST90003972 | 1.95 |
| 3029 | Eye problems/disorders - Cataract | Eyesight | UKBB00000230 | 1.95 |
| 3030 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 1.95 |
| 3031 | CXADR/GGT1 ratio | GCST90314328 | 1.95 |
| 3032 | IDP dMRI ProbtrackX ICVF cgh l | GCST90004381 | 1.95 |
| 3033 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454 | ECGU000454 | 1.95 |
| 3034 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276 | ECGU000276 | 1.95 |
| 3035 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80) | GCST90320643 | 1.94 |
| 3036 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499 | ECGU000499 | 1.94 |
| 3037 | Plasma ascorbic acid 2-sulfate levels in chronic kidney disease | GCST90264832 | 1.94 |
| 3038 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38 | ECGA000038 | 1.94 |
| 3039 | Volume of right whole amygdala | GCST90475054 | 1.94 |
| 3040 | REN levels | GCST90470454 | 1.94 |
| 3041 | aparc-DKTatlas lh volume pericalcarine | GCST90002881 | 1.93 |
| 3042 | AAMDC levels | GCST90468186 | 1.93 |
| 3043 | Vitamin D levels | GCST005367 | 1.93 |
| 3044 | Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302696 | 1.93 |
| 3045 | T1 FreeSurfer aseg CC Posterior | GCST90384175 | 1.92 |
| 3046 | Right ventricular ejection fraction | GCST90134591 | 1.92 |
| 3047 | Tea difference liking | GCST90094855 | 1.92 |
| 3048 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395 | ECGU000395 | 1.92 |
| 3049 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 1.92 |
| 3050 | Hemoglobin | GCST90278631 | 1.91 |
| 3051 | ICD10 N84: Polyp of female genital tract | GCST90454216 | 1.91 |
| 3052 | Kidney transplant status | FING00000710 | 1.91 |
| 3053 | Hernia of abdominal wall, postoperative | FING00000618 | 1.91 |
| 3054 | Creatinine (enzymatic) in urine | Urine assays | UKBB00000155 | 1.91 |
| 3055 | SCRG1 levels | GCST90470554 | 1.91 |
| 3056 | CCL11 levels | GCST90274764 | 1.90 |
| 3057 | Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary Operations | UKBB00000577 | 1.90 |
| 3058 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78 | ECGA000078 | 1.90 |
| 3059 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 1.90 |
| 3060 | Brainstem global volume Medulla | GCST90002764 | 1.90 |
| 3061 | AGER levels | GCST90468252 | 1.90 |
| 3062 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus L | GCST90004368 | 1.90 |
| 3063 | aparc-DKTatlas lh volume lateraloccipital | GCST90002871 | 1.89 |
| 3064 | Retinal arteriolar width | GCST90270398 | 1.89 |
| 3065 | IDP dMRI TBSS L2 Tapetum L | GCST90004170 | 1.89 |
| 3066 | BA-exvivo rh area BA45 | GCST90003229 | 1.89 |
| 3067 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 1.88 |
| 3068 | Pain in thoracic spine | FING00001139 | 1.88 |
| 3069 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | GCST90004370 | 1.87 |
| 3070 | CLEC4D levels | GCST90468773 | 1.87 |
| 3071 | EREG/MPI ratio | GCST90314705 | 1.87 |
| 3072 | aseg rh intensity Accumbens-area | GCST90003788 | 1.87 |
| 3073 | Cardiomyopathy (excluding other) | FING00000251 | 1.87 |
| 3074 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 1.87 |
| 3075 | CX3CL1/DSG2 ratio | GCST90314323 | 1.87 |
| 3076 | Volume of right basal nucleus | GCST90475012 | 1.86 |
| 3077 | aseg rh volume Putamen | GCST90002639 | 1.86 |
| 3078 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T219 | ECGA000219 | 1.86 |
| 3079 | ARF6 levels | GCST90468348 | 1.86 |
| 3080 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2 | ECGA000002 | 1.86 |
| 3081 | Phosphatidylcholine (40:8) levels | GCST90025538 | 1.85 |
| 3082 | Cardiac conduction disorders (PheCode 426) | GCST90475952 | 1.85 |
| 3083 | Serine levels | GCST90200415 | 1.85 |
| 3084 | Chronic obstructive pulmonary disease | GCST90018587 | 1.85 |
| 3085 | HDL x low social support interaction (2df test) | GCST90570669 | 1.85 |
| 3086 | IDP dMRI TBSS ISOVF External capsule L | GCST90004510 | 1.85 |
| 3087 | Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302746 | 1.85 |
| 3088 | Ceramide (d18:2/24:1) levels | GCST90024684 | 1.84 |
| 3089 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285 | ECGA000285 | 1.84 |
| 3090 | T1 FreeSurfer aseg 3rd-Ventricle | GCST90384147 | 1.84 |
| 3091 | FCRL2/LY9 ratio | GCST90314799 | 1.84 |
| 3092 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 1.84 |
| 3093 | T1 FreeSurfer DK rh lingual area | GCST90385701 | 1.83 |
| 3094 | EGF/MPIG6B ratio | GCST90314611 | 1.83 |
| 3095 | aseg global intensity WM-hypointensities | GCST90003756 | 1.83 |
| 3096 | Congenital lactase deficiency | FING00000329 | 1.83 |
| 3097 | CEBPB levels | GCST90468700 | 1.83 |
| 3098 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277 | ECGU000277 | 1.83 |
| 3099 | BTN2A1/LILRB4 ratio | GCST90313546 | 1.82 |
| 3100 | CLEC14A/PIK3IP1 ratio | GCST90314080 | 1.82 |
| 3101 | Milk type: Skimmed, semi-skimmed or full cream (UKB data field 1418) | GCST90133005 | 1.82 |
| 3102 | JAM2/RGMB ratio | GCST90315237 | 1.82 |
| 3103 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502397 | 1.82 |
| 3104 | Osteoarthrosis, localized, primary (PheCode 740.11) | GCST90476255 | 1.82 |
| 3105 | MAVS/MED18 ratio | GCST90315389 | 1.82 |
| 3106 | CHAD levels | GCST90468737 | 1.82 |
| 3107 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279 | ECGU000279 | 1.81 |
| 3108 | FGL1 levels | GCST90469235 | 1.81 |
| 3109 | Omega-3 fatty acids to total fatty acids percentage | GCST90502449 | 1.81 |
| 3110 | IDP dMRI ProbtrackX ICVF ilf l | GCST90004389 | 1.81 |
| 3111 | ATG4A/TPMT ratio | GCST90313370 | 1.81 |
| 3112 | Age-related macular degeneration (whether dry or wet) | FING00000047 | 1.81 |
| 3113 | L3HYPDH levels | GCST90469724 | 1.81 |
| 3114 | rfMRI connectivity (ICA100 edge 931) | GCST90005784 | 1.80 |
| 3115 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T157 | ECGU000157 | 1.80 |
| 3116 | Past tobacco smoking | Smoking | UKBB00000635 | 1.80 |
| 3117 | Primary/intrinsic cardiomyopathies (PheCode 425.1) | GCST90475951 | 1.80 |
| 3118 | PIK3AP1 levels | GCST90470233 | 1.80 |
| 3119 | aparc-DKTatlas lh volume parstriangularis | GCST90002880 | 1.80 |
| 3120 | IFIT2 levels | GCST90090864 | 1.80 |
| 3121 | ICD10 N86: Erosion and ectropion of cervix uteri | GCST90454217 | 1.80 |
| 3122 | Seborrheic keratosis (PheCode 702.2) | GCST90476206 | 1.80 |
| 3123 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393 | ECGU000393 | 1.80 |
| 3124 | CX3CL1 levels | GCST90274778 | 1.80 |
| 3125 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 1.80 |
| 3126 | CCN3/COL6A3 ratio | GCST90313720 | 1.79 |
| 3127 | aseg global volume CC-Central | GCST90002609 | 1.79 |
| 3128 | ThalamNuclei lh volume Whole-thalamus | GCST90002762 | 1.79 |
| 3129 | Volume of left whole amygdala | GCST90474988 | 1.79 |
| 3130 | FKBP5/TBCC ratio | GCST90314849 | 1.79 |
| 3131 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T90 | ECGA000090 | 1.79 |
| 3132 | Hematocrit | GCST90002305 | 1.78 |
| 3133 | COLEC12/TAFA5 ratio | GCST90314185 | 1.78 |
| 3134 | MPI levels | GCST90469936 | 1.78 |
| 3135 | BA-exvivo lh area BA6 | GCST90003213 | 1.78 |
| 3136 | Other infective otitis externa | FING00001060 | 1.78 |
| 3137 | GPHA2 levels | GCST90469389 | 1.77 |
| 3138 | DLL4 levels | GCST90469005 | 1.77 |
| 3139 | FUS levels | GCST90469278 | 1.77 |
| 3140 | Other diseases of intestines | FING00001001 | 1.77 |
| 3141 | LEP levels | GCST003368 | 1.77 |
| 3142 | Bladder stone | GCST90468116 | 1.77 |
| 3143 | CST3/TFF3 ratio | GCST90314299 | 1.77 |
| 3144 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172 | ECGA000172 | 1.76 |
| 3145 | RABGAP1L levels | GCST90470416 | 1.76 |
| 3146 | JAM2/TNFRSF14 ratio | GCST90315240 | 1.76 |
| 3147 | PTPRS levels | GCST90470387 | 1.76 |
| 3148 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T120 | ECGU000120 | 1.76 |
| 3149 | Leg fat percentage (left) | Impedance measures | UKBB00000391 | 1.75 |
| 3150 | Breathing problems responsible for leaving job | Employment history | UKBB00000112 | 1.75 |
| 3151 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394 | ECGU000394 | 1.75 |
| 3152 | Lung volume | GCST90016668 | 1.75 |
| 3153 | MMP3 levels | GCST90469920 | 1.75 |
| 3154 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181 | ECGU000181 | 1.74 |
| 3155 | Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74) | GCST90668518 | 1.74 |
| 3156 | Stroke | GCST006906 | 1.74 |
| 3157 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 1.74 |
| 3158 | SLITRK2 levels | GCST90470670 | 1.74 |
| 3159 | LTBP2/PDGFRA ratio | GCST90315338 | 1.74 |
| 3160 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26 | ECGA000026 | 1.74 |
| 3161 | Ischemic stroke | GCST006908 | 1.74 |
| 3162 | MB levels | GCST90012047 | 1.74 |
| 3163 | Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) | FING00000041 | 1.74 |
| 3164 | ELOA levels | GCST90469104 | 1.74 |
| 3165 | Atrophic disorders of skin | FING00000129 | 1.74 |
| 3166 | T1 CAT volume L VIIIa | GCST90384127 | 1.73 |
| 3167 | IDP dMRI TBSS ISOVF Corticospinal tract R | GCST90004483 | 1.73 |
| 3168 | Stroke (MTAG) | GCST90449063 | 1.73 |
| 3169 | wg rh intensity-contrast frontalpole | GCST90003858 | 1.73 |
| 3170 | aseg global volume EstimatedTotalIntraCranial | GCST90002597 | 1.73 |
| 3171 | SNX15 levels | GCST90470699 | 1.73 |
| 3172 | Artrosis, including avohilmo | FING00000112 | 1.72 |
| 3173 | aparc-a2009s rh area G+S-subcentral | GCST90003374 | 1.72 |
| 3174 | CD59/CST6 ratio | GCST90313857 | 1.72 |
| 3175 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97 | ECGA000097 | 1.72 |
| 3176 | SSC5D levels | GCST90470748 | 1.71 |
| 3177 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T343 | ECGA000343 | 1.71 |
| 3178 | ORM1 levels | GCST90470129 | 1.71 |
| 3179 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule R | GCST90004095 | 1.71 |
| 3180 | Benign lipomatous neoplasm | FING00000146 | 1.71 |
| 3181 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168 | ECGA000168 | 1.70 |
| 3182 | IDP dMRI TBSS L2 Uncinate fasciculus R | GCST90004167 | 1.70 |
| 3183 | Non-cancer illness code, self-reported - hiatus hernia | Medical conditions | UKBB00000515 | 1.70 |
| 3184 | Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels | GCST90060395 | 1.70 |
| 3185 | Cerebrovascular disease (PheCode 433) | GCST90475985 | 1.70 |
| 3186 | Intestinal infectious diseases | FING00000689 | 1.70 |
| 3187 | wg lh intensity-contrast bankssts | GCST90003793 | 1.70 |
| 3188 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5) | GCST90320568 | 1.69 |
| 3189 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025115 | 1.69 |
| 3190 | High blood pressure / hypertension | GCST90475214 | 1.69 |
| 3191 | KRT5 levels | GCST90469718 | 1.69 |
| 3192 | Liver iron content | GCST90016674 | 1.69 |
| 3193 | DAG1/PDGFB ratio | GCST90314379 | 1.69 |
| 3194 | DTI autoptx L2 unc l tract | GCST90385191 | 1.68 |
| 3195 | Osteoarthritis | GCST90476383 | 1.68 |
| 3196 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344 | ECGA000344 | 1.68 |
| 3197 | aparc-a2009s lh thickness S-cingul-Marginalis | GCST90003648 | 1.68 |
| 3198 | aparc-DKTatlas rh area caudalmiddlefrontal | GCST90003267 | 1.68 |
| 3199 | EDAR/IPCEF1 ratio | GCST90314578 | 1.68 |
| 3200 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392 | ECGU000392 | 1.68 |
| 3201 | CD84/GP1BA ratio | GCST90313913 | 1.68 |
| 3202 | Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302751 | 1.68 |
| 3203 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169 | ECGA000169 | 1.67 |
| 3204 | TNFRSF14/TNFSF14 ratio | GCST90315936 | 1.67 |
| 3205 | IDP dMRI TBSS L3 Sagittal stratum R | GCST90004201 | 1.67 |
| 3206 | AZU1/MPO ratio | GCST90313425 | 1.67 |
| 3207 | ANGPTL2 levels | GCST90468303 | 1.67 |
| 3208 | red blood cell count (RBC, mean, inv-norm transformed) | GCST90476347 | 1.67 |
| 3209 | CSTB levels | GCST90179272 | 1.66 |
| 3210 | NID1/TIMP3 ratio | GCST90315543 | 1.66 |
| 3211 | Diabetes type 2 with peripheral circulatory (PheCode 250.25) | GCST90475678 | 1.66 |
| 3212 | Cerebrospinal fluid sulfate* levels | GCST90318056 | 1.66 |
| 3213 | IDP dMRI TBSS MO Superior corona radiata L | GCST90003977 | 1.65 |
| 3214 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73 | ECGA000073 | 1.65 |
| 3215 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120 | ECGA000120 | 1.65 |
| 3216 | Volume of right lateral nucleus | GCST90475039 | 1.65 |
| 3217 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121 | ECGA000121 | 1.65 |
| 3218 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T94 | ECGA000094 | 1.65 |
| 3219 | IDP dMRI TBSS L3 Anterior corona radiata R | GCST90004193 | 1.65 |
| 3220 | DNPH1/PDGFB ratio | GCST90314527 | 1.64 |
| 3221 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93 | ECGA000093 | 1.64 |
| 3222 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398 | ECGU000398 | 1.64 |
| 3223 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 1.64 |
| 3224 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178 | ECGU000178 | 1.64 |
| 3225 | Medication use (antihypertensives) | GCST90018764 | 1.64 |
| 3226 | CCN3/PGF ratio | GCST90313722 | 1.64 |
| 3227 | CPXM1/LGMN ratio | GCST90314220 | 1.64 |
| 3228 | wg rh intensity-contrast paracentral | GCST90003843 | 1.64 |
| 3229 | Alzheimer's disease (MTAG) | GCST90449055 | 1.64 |
| 3230 | IDP dMRI TBSS ICVF Posterior corona radiata R | GCST90004353 | 1.63 |
| 3231 | FOLH1 levels | GCST90427192 | 1.63 |
| 3232 | REST UKBBICA NET100 1111 | GCST90386965 | 1.63 |
| 3233 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T352 | ECGA000352 | 1.63 |
| 3234 | CTSF/CTSV ratio | GCST90314313 | 1.63 |
| 3235 | Antihypertensive medication - note that there are other indications | FING00000097 | 1.63 |
| 3236 | CA5A/KRT18 ratio | GCST90313592 | 1.63 |
| 3237 | FCRL5/TNFRSF13B ratio | GCST90314805 | 1.63 |
| 3238 | IDP dMRI TBSS OD Posterior corona radiata L | GCST90004429 | 1.63 |
| 3239 | Platelet count during second trimester of pregnancy | GCST90302225 | 1.62 |
| 3240 | aseg lh volume Putamen | GCST90002622 | 1.62 |
| 3241 | CXCL3/MGLL ratio | GCST90314345 | 1.62 |
| 3242 | IGFBP6 levels | GCST90469531 | 1.62 |
| 3243 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T281 | ECGU000281 | 1.62 |
| 3244 | CELA3A/CTRB1 ratio | GCST90314011 | 1.62 |
| 3245 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417 | ECGU000417 | 1.62 |
| 3246 | ATXN10/SLC27A4 ratio | GCST90313399 | 1.61 |
| 3247 | AMBP/EFEMP1 ratio | GCST90313253 | 1.61 |
| 3248 | CD58/MCAM ratio | GCST90313852 | 1.61 |
| 3249 | aparc-a2009s lh area S-orbital-H-Shaped | GCST90003360 | 1.61 |
| 3250 | SRPK2 levels | GCST90470743 | 1.61 |
| 3251 | Left-hemisphere control network to putamen white-matter structural connectivity | GCST90302754 | 1.61 |
| 3252 | PDGFB/TIMP3 ratio | GCST90315631 | 1.61 |
| 3253 | Atrial fibrillation (PheCode 427.21) | GCST90475970 | 1.61 |
| 3254 | Placental weight (maternal genotype, adjusted for sex and gestational age) | GCST90275190 | 1.61 |
| 3255 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286 | ECGA000286 | 1.61 |
| 3256 | CD46/THBD ratio | GCST90313836 | 1.61 |
| 3257 | IFNGR1/THBD ratio | GCST90315130 | 1.61 |
| 3258 | CLIP2 levels | GCST90468782 | 1.60 |
| 3259 | IDP dMRI TBSS L3 Cingulum cingulate gyrus R | GCST90004205 | 1.60 |
| 3260 | Total Ceramide levels | GCST90025817 | 1.60 |
| 3261 | Brain age gap | GCST90558034 | 1.60 |
| 3262 | Cardiomyopathy | GCST90399705 | 1.60 |
| 3263 | Hippocampal left GC-ML-DG volume (head) | GCST90267946 | 1.60 |
| 3264 | BPIFB2 levels | GCST90468463 | 1.60 |
| 3265 | CDH5/NOTCH1 ratio | GCST90313957 | 1.59 |
| 3266 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T345 | ECGA000345 | 1.59 |
| 3267 | Thyroid stimulating hormone levels within normal range in pregnancy | GCST90435195 | 1.59 |
| 3268 | Right subiculum volume (body) | GCST90267980 | 1.59 |
| 3269 | Volume of right whole amygdala | GCST90474931 | 1.59 |
| 3270 | Metabolonic lactone sulfate levels | GCST90200257 | 1.59 |
| 3271 | CCDC80/CCL27 ratio | GCST90313669 | 1.58 |
| 3272 | Phosphatidylethanolamine_35:2_[M-H]1- levels | GCST90060260 | 1.58 |
| 3273 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T260 | ECGU000260 | 1.58 |
| 3274 | DTI TBSS L3 Anterior corona radiata R | GCST90384546 | 1.58 |
| 3275 | CD302 levels | GCST90468624 | 1.58 |
| 3276 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T298 | ECGA000298 | 1.58 |
| 3277 | IDP dMRI TBSS L1 Cerebral peduncle R | GCST90004089 | 1.57 |
| 3278 | aparc-a2009s rh area S-oc-temp-med+Lingual | GCST90003431 | 1.57 |
| 3279 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396 | ECGU000396 | 1.57 |
| 3280 | Right hippocampal volume (tail) | GCST90267973 | 1.57 |
| 3281 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463 | ECGU000463 | 1.57 |
| 3282 | TRIM5 levels | GCST90470970 | 1.57 |
| 3283 | Butternut squash liking | GCST90094718 | 1.57 |
| 3284 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174 | ECGA000174 | 1.57 |
| 3285 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T349 | ECGA000349 | 1.57 |
| 3286 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320898 | 1.57 |
| 3287 | Breast size | GCST006655 | 1.56 |
| 3288 | APOM levels | GCST90468342 | 1.56 |
| 3289 | Treatment/medication code - gliclazide | Medications | UKBB00000846 | 1.56 |
| 3290 | ENO2/MGLL ratio | GCST90314663 | 1.56 |
| 3291 | SNAP25 levels | GCST90422083 | 1.56 |
| 3292 | ANXA3/EDAR ratio | GCST90313280 | 1.56 |
| 3293 | Varicose veins | circulatory system | UKBB00000893 | 1.56 |
| 3294 | COCH levels | GCST90468810 | 1.56 |
| 3295 | Other disorders of amino-acid metabolism | FING00001014 | 1.56 |
| 3296 | ENG/NCAM2 ratio | GCST90314647 | 1.55 |
| 3297 | FKBP4/WWP2 ratio | GCST90314842 | 1.55 |
| 3298 | aparc-Desikan lh volume supramarginal | GCST90002798 | 1.55 |
| 3299 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | GCST90475168 | 1.55 |
| 3300 | ART3 levels | GCST90468370 | 1.55 |
| 3301 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70) | GCST90320889 | 1.55 |
| 3302 | Age high blood pressure diagnosed | Medical conditions | UKBB00000016 | 1.55 |
| 3303 | CLEC1B/MGLL ratio | GCST90314097 | 1.54 |
| 3304 | End-diastolic bi-ventricular shape (principal component 1) | GCST90448480 | 1.54 |
| 3305 | Volume of right anterior amygdaloid area | GCST90475003 | 1.54 |
| 3306 | LILRB4 levels | GCST90426708 | 1.54 |
| 3307 | NOS3 levels | GCST90470064 | 1.54 |
| 3308 | 5alpha-pregnan-3beta,20alpha-diol disulfate levels | GCST90199838 | 1.54 |
| 3309 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320885 | 1.54 |
| 3310 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179 | ECGU000179 | 1.53 |
| 3311 | Triacylglycerol (54:2) [NL-18:0] levels | GCST90025175 | 1.52 |
| 3312 | DCBLD2 levels | GCST90468952 | 1.52 |
| 3313 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T227 | ECGA000227 | 1.52 |
| 3314 | Cardiovascular diseases (excluding rheumatic etc) | FING00000255 | 1.52 |
| 3315 | CTHRC1 levels | GCST90468902 | 1.52 |
| 3316 | Takes medication for high blood pressure? | GCST90475216 | 1.51 |
| 3317 | PIK3IP1/RGMB ratio | GCST90315652 | 1.51 |
| 3318 | T1 FreeSurfer aseg lhCerebralWhiteMatterVol | GCST90384185 | 1.51 |
| 3319 | IDP T1 FAST ROIs L hippocampus | GCST90002555 | 1.51 |
| 3320 | CASP10/ING1 ratio | GCST90313625 | 1.51 |
| 3321 | Facial pigmentation measurement (UV light) | GCST90002283 | 1.51 |
| 3322 | NFATC1/SPRY2 ratio | GCST90315539 | 1.51 |
| 3323 | Calcium levels | GCST90018731 | 1.51 |
| 3324 | X-11550 levels | GCST90243648 | 1.50 |
| 3325 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320629 | 1.50 |
| 3326 | HSDL2 levels | GCST90469485 | 1.50 |
| 3327 | IL15RA levels | GCST90469555 | 1.50 |
| 3328 | 4-androsten-3beta,17beta-diol disulfate 2 levels | GCST90243880 | 1.50 |
| 3329 | Volume of right accessory basal nucleus | GCST90474907 | 1.50 |
| 3330 | Atopic dermatitis | GCST90018564 | 1.49 |
| 3331 | Frequency of travelling from home to job workplace | Employment | UKBB00000269 | 1.49 |
| 3332 | ERBIN/TBC1D23 ratio | GCST90314698 | 1.49 |
| 3333 | EGFR/MEGF9 ratio | GCST90314614 | 1.49 |
| 3334 | Depression/anxiety (weighted GWA) | GCST90267277 | 1.49 |
| 3335 | F5 levels | GCST90446466 | 1.48 |
| 3336 | Job involves shift work | Employment | UKBB00000385 | 1.48 |
| 3337 | aparc-Desikan lh volume pericalcarine | GCST90002788 | 1.48 |
| 3338 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 1.48 |
| 3339 | Ever highly irritable/argumentative for 2 days | Mental health | UKBB00000219 | 1.48 |
| 3340 | CNTN5 levels | GCST90468807 | 1.48 |
| 3341 | CALCOCO1/DCTN1 ratio | GCST90313600 | 1.47 |
| 3342 | Serum urea levels | GCST90025991 | 1.47 |
| 3343 | GGT1/IL1RL2 ratio | GCST90314929 | 1.47 |
| 3344 | Volume of right anterior amygdaloid area | GCST90474904 | 1.47 |
| 3345 | FNDC1 levels | GCST90469256 | 1.47 |
| 3346 | ENG levels | GCST90469108 | 1.47 |
| 3347 | 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels | GCST90200685 | 1.47 |
| 3348 | Social and economic stability (confirmatory factor analysis Factor 15) | GCST90309349 | 1.46 |
| 3349 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T456 | ECGA000456 | 1.46 |
| 3350 | IDP dMRI ProbtrackX ICVF ifo l | GCST90004387 | 1.46 |
| 3351 | USP25 levels | GCST90471019 | 1.46 |
| 3352 | Resting heart rate | GCST90278636 | 1.46 |
| 3353 | Muscular dystrophy | FING00000848 | 1.46 |
| 3354 | IDP T1 FAST ROIs L planum temporale | GCST90002541 | 1.46 |
| 3355 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391 | ECGU000391 | 1.45 |
| 3356 | aseg rh volume Caudate | GCST90002638 | 1.45 |
| 3357 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415 | ECGU000415 | 1.45 |
| 3358 | T1 FreeSurfer BA lh BA4p exvivo thickness | GCST90385524 | 1.45 |
| 3359 | C3 levels | GCST90281041 | 1.45 |
| 3360 | NOTCH3/PTPRS ratio | GCST90315547 | 1.45 |
| 3361 | Total testosterone levels | GCST90239819 | 1.45 |
| 3362 | SPINK2 levels | GCST90470722 | 1.45 |
| 3363 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T122 | ECGA000122 | 1.44 |
| 3364 | aseg global volume 3rd-Ventricle | GCST90002599 | 1.44 |
| 3365 | IDP dMRI TBSS L1 Cingulum hippocampus L | GCST90004112 | 1.44 |
| 3366 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T115 | ECGA000115 | 1.44 |
| 3367 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448 | ECGU000448 | 1.44 |
| 3368 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T123 | ECGA000123 | 1.44 |
| 3369 | Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels | GCST90200098 | 1.44 |
| 3370 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491 | ECGA000491 | 1.44 |
| 3371 | IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R | GCST90004511 | 1.44 |
| 3372 | Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levels | GCST90060375 | 1.43 |
| 3373 | COL5A1 levels | GCST90468820 | 1.43 |
| 3374 | CD46/NECTIN2 ratio | GCST90313832 | 1.43 |
| 3375 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T346 | ECGA000346 | 1.43 |
| 3376 | CIAPIN1/SPARC ratio | GCST90314069 | 1.43 |
| 3377 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025743 | 1.43 |
| 3378 | DSG4 levels | GCST90469044 | 1.43 |
| 3379 | CDH6/NTRK2 ratio | GCST90313962 | 1.43 |
| 3380 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476363 | 1.42 |
| 3381 | Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels | GCST90060298 | 1.42 |
| 3382 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 1.42 |
| 3383 | rfMRI connectivity (ICA100 edge 1099) | GCST90005952 | 1.42 |
| 3384 | HippSubfield rh volume CA3-head | GCST90002707 | 1.42 |
| 3385 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74) | GCST90320637 | 1.42 |
| 3386 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T140 | ECGU000140 | 1.42 |
| 3387 | wg lh intensity-contrast frontalpole | GCST90003823 | 1.42 |
| 3388 | CD59/SCARB2 ratio | GCST90313859 | 1.42 |
| 3389 | BECN1 levels | GCST90468438 | 1.42 |
| 3390 | TIMM8A levels | GCST90470868 | 1.42 |
| 3391 | PON2/PON3 ratio | GCST90315703 | 1.42 |
| 3392 | Urea | Blood biochemistry | UKBB00000885 | 1.41 |
| 3393 | EEF1D levels | GCST90469075 | 1.41 |
| 3394 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50 | ECGA000050 | 1.41 |
| 3395 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T113 | ECGA000113 | 1.41 |
| 3396 | Plasma X-25279 levels in chronic kidney disease | GCST90266835 | 1.41 |
| 3397 | Fibroblastic disorders | FING00000542 | 1.41 |
| 3398 | Spread type - Never/rarely use spread | Diet | UKBB00000794 | 1.41 |
| 3399 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T151 | ECGU000151 | 1.40 |
| 3400 | METAP2 levels | GCST90469894 | 1.40 |
| 3401 | ZNF830 levels | GCST90471102 | 1.40 |
| 3402 | Pulmonary tuberculosis | GCST90018672 | 1.40 |
| 3403 | Nonsuppurative otitis media | FING00000885 | 1.40 |
| 3404 | Lysoalkenylphosphatidylethanolamine (P-20:0) levels | GCST90025460 | 1.40 |
| 3405 | PPP1R9B levels | GCST90470305 | 1.40 |
| 3406 | ZBTB16 levels | GCST90471095 | 1.40 |
| 3407 | GGCT levels | GCST90469334 | 1.40 |
| 3408 | ThalamNuclei lh volume VPL | GCST90002717 | 1.40 |
| 3409 | CCL20 levels | GCST90468572 | 1.40 |
| 3410 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452 | ECGU000452 | 1.40 |
| 3411 | CLIP2/DAB2 ratio | GCST90314124 | 1.40 |
| 3412 | DKK4/REG1A ratio | GCST90314489 | 1.39 |
| 3413 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180 | ECGU000180 | 1.39 |
| 3414 | NTRK3 levels | GCST90470098 | 1.39 |
| 3415 | NAP1L4 levels | GCST90469998 | 1.39 |
| 3416 | Physical activity (Total log acceleration 8am-10am) | GCST90061413 | 1.39 |
| 3417 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T221 | ECGA000221 | 1.39 |
| 3418 | GPNMB levels | GCST90469393 | 1.39 |
| 3419 | Other cataract | Disorders of lens | UKBB00000602 | 1.39 |
| 3420 | ERP44 levels | GCST90469150 | 1.39 |
| 3421 | aparc-a2009s lh volume S-calcarine | GCST90002968 | 1.39 |
| 3422 | Right-hemisphere control network to accumbens white-matter structural connectivity | GCST90302842 | 1.39 |
| 3423 | Varicose veins of lower extremity | circulatory system | UKBB00000895 | 1.39 |
| 3424 | Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2) | GCST90132969 | 1.38 |
| 3425 | ANGPTL3/TFPI ratio | GCST90313270 | 1.38 |
| 3426 | ALB levels | GCST90497108 | 1.38 |
| 3427 | IDP dMRI ProbtrackX ICVF unc r | GCST90004401 | 1.38 |
| 3428 | PPP2R2A levels | GCST90618122 | 1.38 |
| 3429 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462 | ECGU000462 | 1.38 |
| 3430 | Birth size (multivariate analysis) | GCST90624101 | 1.38 |
| 3431 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152 | ECGU000152 | 1.38 |
| 3432 | ADM levels | GCST90011996 | 1.38 |
| 3433 | DNM1 levels | GCST90469021 | 1.38 |
| 3434 | FGF23 levels | GCST90469223 | 1.38 |
| 3435 | Time spent watching television (TV) | Physical activity | UKBB00000821 | 1.38 |
| 3436 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71) | GCST90320634 | 1.38 |
| 3437 | PTPN6/YES1 ratio | GCST90315750 | 1.38 |
| 3438 | DTI autoptx L3 unc l tract | GCST90385218 | 1.38 |
| 3439 | Calcium | Blood biochemistry | UKBB00000114 | 1.38 |
| 3440 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320687 | 1.37 |
| 3441 | IDP dMRI ProbtrackX L2 fma | GCST90004283 | 1.37 |
| 3442 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47 | ECGA000047 | 1.37 |
| 3443 | Low density lipoprotein cholesterol levels | GCST90239657 | 1.37 |
| 3444 | MGLL/PDLIM7 ratio | GCST90315438 | 1.37 |
| 3445 | 2-hydroxyisobutyrate levels | GCST90243539 | 1.37 |
| 3446 | BCAN/NPTXR ratio | GCST90313482 | 1.37 |
| 3447 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 1.37 |
| 3448 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16 | ECGA000016 | 1.37 |
| 3449 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 1.36 |
| 3450 | PTPRM levels | GCST90470384 | 1.36 |
| 3451 | AFM levels | GCST90468249 | 1.36 |
| 3452 | Principal component-derived dietary pattern 40 | GCST90133045 | 1.36 |
| 3453 | wg lh intensity-contrast precentral | GCST90003815 | 1.36 |
| 3454 | PCYT2 levels | GCST90470178 | 1.36 |
| 3455 | NEXN levels | GCST90470030 | 1.36 |
| 3456 | Operation code - coronary angioplasty (ptca) +/- stent | Operations | UKBB00000555 | 1.36 |
| 3457 | Aplastic anemia (PheCode 284) | GCST90475783 | 1.36 |
| 3458 | Polyarthrosis | FING00001181 | 1.35 |
| 3459 | Volume of right cortical nucleus | GCST90474919 | 1.35 |
| 3460 | CCL17/THPO ratio | GCST90313689 | 1.35 |
| 3461 | Treatment/medication code - bendroflumethiazide | Medications | UKBB00000843 | 1.35 |
| 3462 | MANF/PTPN6 ratio | GCST90315366 | 1.35 |
| 3463 | ODAM levels | GCST90470115 | 1.35 |
| 3464 | Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenum | UKBB00000606 | 1.35 |
| 3465 | wg rh intensity-contrast pericalcarine | GCST90003847 | 1.35 |
| 3466 | DTI TBSS MD Splenium of corpus callosum | GCST90384576 | 1.35 |
| 3467 | CST3/RETN ratio | GCST90314297 | 1.34 |
| 3468 | ACVRL1/TNFRSF19 ratio | GCST90313159 | 1.34 |
| 3469 | REN levels | GCST90012038 | 1.34 |
| 3470 | DAB2/ERBIN ratio | GCST90314361 | 1.34 |
| 3471 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000442 | 1.34 |
| 3472 | Intervertebral disc disorders (PheCode 722) | GCST90476237 | 1.34 |
| 3473 | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | GCST90302765 | 1.34 |
| 3474 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408 | ECGU000408 | 1.34 |
| 3475 | EPHA1 levels | GCST90469129 | 1.34 |
| 3476 | LAMP1 levels | GCST90469733 | 1.33 |
| 3477 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 89) | GCST90320652 | 1.33 |
| 3478 | Volume of left whole amygdala | GCST90474898 | 1.33 |
| 3479 | Plasma mannonate* levels in chronic kidney disease | GCST90265479 | 1.33 |
| 3480 | aparc-Desikan rh thickness transversetemporal | GCST90003511 | 1.33 |
| 3481 | CELA3A levels | GCST90468702 | 1.33 |
| 3482 | aseg rh volume Pallidum | GCST90002640 | 1.33 |
| 3483 | SLC39A5 levels | GCST90470661 | 1.33 |
| 3484 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 1.33 |
| 3485 | CLSTN3 levels | GCST90468790 | 1.33 |
| 3486 | MAPK9 levels | GCST90469857 | 1.32 |
| 3487 | Abdominal subcutaneous adipose tissue normalized | GCST90267348 | 1.32 |
| 3488 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T458 | ECGA000458 | 1.32 |
| 3489 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 1.32 |
| 3490 | DPY30 levels | GCST90469037 | 1.32 |
| 3491 | SMOC2 levels | GCST90060059 | 1.32 |
| 3492 | EDAR/YES1 ratio | GCST90314594 | 1.32 |
| 3493 | Personality disorders (more control exclusions) | FING00001163 | 1.32 |
| 3494 | MEGF10 levels | GCST90469882 | 1.32 |
| 3495 | ACADSB levels | GCST90468195 | 1.32 |
| 3496 | Volume of left lateral nucleus | GCST90474973 | 1.32 |
| 3497 | Type 2 diabetes with renal manifestations (PheCode 250.22) | GCST90475670 | 1.31 |
| 3498 | ISM1 levels | GCST90469630 | 1.31 |
| 3499 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 1.31 |
| 3500 | F9/FETUB ratio | GCST90314746 | 1.31 |
| 3501 | DPP7 levels | GCST90469035 | 1.31 |
| 3502 | JAM2/TNFRSF19 ratio | GCST90315241 | 1.31 |
| 3503 | Body fat percentage | Impedance measures | UKBB00000102 | 1.31 |
| 3504 | TNC/VCAM1 ratio | GCST90315927 | 1.30 |
| 3505 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T397 | ECGU000397 | 1.30 |
| 3506 | DAB2/NCK2 ratio | GCST90314367 | 1.30 |
| 3507 | TNFRSF12A levels | GCST90470904 | 1.30 |
| 3508 | aseg global volume BrainSegNotVent | GCST90002591 | 1.30 |
| 3509 | DEFB4A or DEFB4B levels | GCST90468984 | 1.30 |
| 3510 | IDP dMRI TBSS L3 Anterior limb of internal capsule L | GCST90004188 | 1.30 |
| 3511 | Central pulse pressure | GCST90267387 | 1.29 |
| 3512 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T347 | ECGA000347 | 1.29 |
| 3513 | aparc-a2009s lh thickness Pole-occipital | GCST90003644 | 1.29 |
| 3514 | DTI autoptx MD unc l tract | GCST90385245 | 1.29 |
| 3515 | Migraine without aura and triptan purchases | FING00000822 | 1.29 |
| 3516 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174 | ECGU000174 | 1.29 |
| 3517 | RAB6A levels | GCST90470412 | 1.29 |
| 3518 | FGF23 levels | GCST90012022 | 1.29 |
| 3519 | CCL8 levels | GCST90422346 | 1.28 |
| 3520 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5 | ECGA000005 | 1.28 |
| 3521 | NPDC1 levels | GCST90470069 | 1.28 |
| 3522 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278 | ECGU000278 | 1.28 |
| 3523 | PGA4 levels | GCST90470216 | 1.28 |
| 3524 | PLA2G4A/PPP1R12A ratio | GCST90315666 | 1.28 |
| 3525 | Volume of right medial nucleus | GCST90474925 | 1.28 |
| 3526 | CXCL17/SFTPA2 ratio | GCST90314341 | 1.28 |
| 3527 | Acute sinusitis | FING00000031 | 1.28 |
| 3528 | Breast cancer | GCST90429846 | 1.28 |
| 3529 | Varicose veins (PheCode 454) | GCST90476012 | 1.28 |
| 3530 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 1.28 |
| 3531 | IPCEF1/TBCC ratio | GCST90315188 | 1.28 |
| 3532 | EPO/TFRC ratio | GCST90314684 | 1.28 |
| 3533 | Calcium levels | GCST90025990 | 1.28 |
| 3534 | Father's age at death | Family history | UKBB00000241 | 1.28 |
| 3535 | Charcot foot | FING00000268 | 1.28 |
| 3536 | NRCAM/PCDH17 ratio | GCST90315553 | 1.27 |
| 3537 | Treatment/medication code - ramipril | Medications | UKBB00000856 | 1.27 |
| 3538 | Flat foot (PheCode 735.1) | GCST90476248 | 1.27 |
| 3539 | IDP dMRI ProbtrackX FA ilf r | GCST90003940 | 1.27 |
| 3540 | NPTX1 levels | GCST90470078 | 1.27 |
| 3541 | Operation code - hysterectomy | Operations | UKBB00000559 | 1.27 |
| 3542 | PAMR1 levels | GCST90470155 | 1.27 |
| 3543 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320641 | 1.27 |
| 3544 | Volume of left paralaminar nucleus | GCST90474982 | 1.27 |
| 3545 | aparc-DKTatlas rh thickness pericalcarine | GCST90003590 | 1.27 |
| 3546 | wg rh intensity-contrast precuneus | GCST90003851 | 1.27 |
| 3547 | Acid reflux/GERD | GCST90475320 | 1.27 |
| 3548 | COMP/MYOC ratio | GCST90314191 | 1.26 |
| 3549 | WFIKKN1 levels | GCST90471076 | 1.26 |
| 3550 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T104 | ECGA000104 | 1.26 |
| 3551 | CRIM1/NRP2 ratio | GCST90314261 | 1.26 |
| 3552 | 21-hydroxypregnenolone disulfate levels | GCST90199849 | 1.26 |
| 3553 | aparc-pial lh area pericalcarine | GCST90003161 | 1.26 |
| 3554 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65 | ECGA000065 | 1.26 |
| 3555 | Beef consumption (UKB data field 1369) | GCST90132997 | 1.26 |
| 3556 | OMD/SOST ratio | GCST90315585 | 1.26 |
| 3557 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T348 | ECGA000348 | 1.26 |
| 3558 | IGF1 levels | GCST90102623 | 1.26 |
| 3559 | Chronic pain (confirmatory factor analysis Factor 18) | GCST90309352 | 1.26 |
| 3560 | AKT2 levels | GCST90468277 | 1.25 |
| 3561 | CETN2/TDRKH ratio | GCST90314031 | 1.25 |
| 3562 | CFHR4 levels | GCST90019045 | 1.25 |
| 3563 | Nonalcoholic fatty liver disease | GCST90091033 | 1.25 |
| 3564 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71 | ECGA000071 | 1.25 |
| 3565 | STAB2 levels | GCST90470755 | 1.25 |
| 3566 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 1.25 |
| 3567 | MANSC1/PODXL ratio | GCST90315372 | 1.25 |
| 3568 | Ceramide (d18:1/24:0) levels | GCST90024046 | 1.25 |
| 3569 | NMI levels | GCST90470056 | 1.25 |
| 3570 | CTSL levels | GCST90012073 | 1.25 |
| 3571 | EGLN1 levels | GCST90469087 | 1.25 |
| 3572 | PDGFB/VEGFC ratio | GCST90315635 | 1.24 |
| 3573 | PDGFB/PPP1R12A ratio | GCST90315623 | 1.24 |
| 3574 | Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivity | GCST90302759 | 1.24 |
| 3575 | FKBP7 levels | GCST90469245 | 1.24 |
| 3576 | Retinal vascular disorders | FING00001262 | 1.24 |
| 3577 | low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed) | GCST90475420 | 1.24 |
| 3578 | T1 FreeSurfer a2009s lh S postcentral area | GCST90384734 | 1.24 |
| 3579 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166 | ECGA000166 | 1.24 |
| 3580 | Added salt consumption | GCST90133001 | 1.24 |
| 3581 | Triacylglycerol_56:4_[M+NH4]1+ levels | GCST90060556 | 1.23 |
| 3582 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 1.23 |
| 3583 | Birth weight | Early life factors | UKBB00000095 | 1.23 |
| 3584 | IDP dMRI ProbtrackX L2 cgc r | GCST90004278 | 1.23 |
| 3585 | CLSTN2/MATN2 ratio | GCST90314143 | 1.23 |
| 3586 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227 | ECGU000227 | 1.23 |
| 3587 | CSRP3 levels | GCST90468892 | 1.23 |
| 3588 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447 | ECGU000447 | 1.23 |
| 3589 | PIBF1 levels | GCST90470231 | 1.23 |
| 3590 | Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels | GCST90060295 | 1.23 |
| 3591 | Left ventricular end-diastolic volume | GCST90268124 | 1.23 |
| 3592 | UXS1 levels | GCST90471023 | 1.22 |
| 3593 | Renal tubulo-interstitial diseases | FING00001251 | 1.22 |
| 3594 | Total protein levels | GCST90025995 | 1.22 |
| 3595 | Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302699 | 1.22 |
| 3596 | FABP1/FABP2 ratio | GCST90314750 | 1.22 |
| 3597 | Isolated hypothyroxinemia in pregnancy | GCST90435198 | 1.22 |
| 3598 | Malignant neoplasm of female breast (PheCode 174.11) | GCST90041833 | 1.22 |
| 3599 | Left ventricular end diastole inferoseptal wall thickness | GCST90278514 | 1.22 |
| 3600 | PGF levels | GCST90470218 | 1.21 |
| 3601 | ENO2/SULT1A1 ratio | GCST90314669 | 1.21 |
| 3602 | Pain medicine use during menstruation | GCST006637 | 1.21 |
| 3603 | CCL27 levels | GCST90468579 | 1.21 |
| 3604 | SELPLG levels | GCST90470568 | 1.21 |
| 3605 | CFB levels | GCST90240778 | 1.21 |
| 3606 | Other and/or unspecified nontoxic goitre | FING00000958 | 1.21 |
| 3607 | TMPRSS11D levels | GCST90470891 | 1.21 |
| 3608 | IRAK1 levels | GCST90469627 | 1.20 |
| 3609 | IRAK4/VASH1 ratio | GCST90315201 | 1.20 |
| 3610 | OPTC levels | GCST90470128 | 1.20 |
| 3611 | Phosphatidylcholine (14:0_22:6) levels | GCST90024234 | 1.20 |
| 3612 | DFFA/FOXO1 ratio | GCST90314456 | 1.20 |
| 3613 | AHNAK2 levels | GCST90468260 | 1.20 |
| 3614 | MINDY1 levels | GCST90469908 | 1.20 |
| 3615 | Recent worrying too much about different things | Anxiety | UKBB00000746 | 1.20 |
| 3616 | wg lh intensity-contrast temporalpole | GCST90003824 | 1.20 |
| 3617 | IDP dMRI ProbtrackX MD fma | GCST90004229 | 1.20 |
| 3618 | IDP dMRI TBSS MD Anterior corona radiata R | GCST90004049 | 1.20 |
| 3619 | Illnesses of siblings - None of the above (group 1) | Family history | UKBB00000353 | 1.20 |
| 3620 | CELA3A/PLA2G1B ratio | GCST90314014 | 1.20 |
| 3621 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T173 | ECGA000173 | 1.19 |
| 3622 | GSR levels | GCST90469410 | 1.19 |
| 3623 | Left-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302668 | 1.19 |
| 3624 | Octadecenedioylcarnitine (C18:1-DC) levels | GCST90199970 | 1.19 |
| 3625 | Hearing loss (PheCode 389) | GCST90475909 | 1.19 |
| 3626 | Heart rate variability (corrected standard deviation of normal-to-normal intervals) | GCST90281266 | 1.19 |
| 3627 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35 | ECGA000035 | 1.19 |
| 3628 | GPIHBP1 levels | GCST90469390 | 1.19 |
| 3629 | CRYZL1 levels | GCST90468878 | 1.19 |
| 3630 | DIABLO/PRKAR1A ratio | GCST90314469 | 1.19 |
| 3631 | Sleep apnoea | FING00001309 | 1.19 |
| 3632 | AKT1S1/MAX ratio | GCST90313230 | 1.19 |
| 3633 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459 | ECGA000459 | 1.19 |
| 3634 | Diabetes (weighted GWA) | GCST90267279 | 1.18 |
| 3635 | HYOU1/THBD ratio | GCST90315106 | 1.18 |
| 3636 | Placental weight (maternal genotype, adjusted for sex) | GCST90275198 | 1.18 |
| 3637 | aseg global volume SupraTentorialNotVent | GCST90002596 | 1.18 |
| 3638 | Cerebrospinal fluid 5-methylthioadenosine (MTA) levels | GCST90318216 | 1.18 |
| 3639 | Free cholesterol in HDL (UKB data field 23422) | GCST90269519 | 1.17 |
| 3640 | Brain glioblastoma, excluding all cancers (controls excluding all cancers) | FING00000225 | 1.17 |
| 3641 | ADGRG2/NRCAM ratio | GCST90313186 | 1.17 |
| 3642 | Plasma propionylcarnitine (C3) levels in chronic kidney disease | GCST90265876 | 1.17 |
| 3643 | GPR37 levels | GCST90469397 | 1.17 |
| 3644 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167 | ECGU000167 | 1.17 |
| 3645 | APP/NID1 ratio | GCST90313326 | 1.17 |
| 3646 | N-formylmethionine levels | GCST90200343 | 1.17 |
| 3647 | Smoking dependency | FING00001315 | 1.17 |
| 3648 | BA-exvivo lh volume BA2 | GCST90002836 | 1.17 |
| 3649 | Late-onset myasthenia gravis | GCST90432158 | 1.17 |
| 3650 | ITGAM levels | GCST90469638 | 1.16 |
| 3651 | Plasma lysine levels in chronic kidney disease | GCST90265459 | 1.16 |
| 3652 | CLMP levels | GCST90468783 | 1.16 |
| 3653 | Trunk fat mass (UKB data field 23128) | GCST90468180 | 1.16 |
| 3654 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418 | ECGU000418 | 1.16 |
| 3655 | CD8 on Effector Memory CD8+ T cell | GCST90002056 | 1.16 |
| 3656 | Aplastic anemia | GCST90018574 | 1.16 |
| 3657 | SEPHS1 levels | GCST90242740 | 1.16 |
| 3658 | Hypertensive heart disease (PheCode 401.21) | GCST90475925 | 1.16 |
| 3659 | IDP dMRI TBSS L3 Posterior limb of internal capsule L | GCST90004190 | 1.16 |
| 3660 | NSFL1C/RILP ratio | GCST90315560 | 1.16 |
| 3661 | aseg rh volume Hippocampus | GCST90002641 | 1.16 |
| 3662 | PPM1B levels | GCST90470296 | 1.16 |
| 3663 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112 | ECGU000112 | 1.15 |
| 3664 | IDP dMRI ProbtrackX L1 unc r | GCST90004272 | 1.15 |
| 3665 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle L | GCST90004338 | 1.15 |
| 3666 | DBNL/HSPA1A ratio | GCST90314418 | 1.15 |
| 3667 | wg lh intensity-contrast transversetemporal | GCST90003825 | 1.15 |
| 3668 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000441 | 1.14 |
| 3669 | MOG/PTPRN2 ratio | GCST90315475 | 1.14 |
| 3670 | IL10 levels | GCST90469546 | 1.14 |
| 3671 | CA4/TGFBR2 ratio | GCST90313588 | 1.14 |
| 3672 | Takes medication for gout? | GCST90476382 | 1.14 |
| 3673 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18 | ECGA000018 | 1.14 |
| 3674 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449 | ECGU000449 | 1.14 |
| 3675 | Foveal thickness | GCST90624113 | 1.14 |
| 3676 | GDF2 levels | GCST90469322 | 1.14 |
| 3677 | Thyroid stimulating hormone levels | GCST90296333 | 1.14 |
| 3678 | IGFBP1 levels | GCST90469527 | 1.14 |
| 3679 | REST UKBBICA NET100 1287 | GCST90387141 | 1.14 |
| 3680 | NAA80 levels | GCST90469990 | 1.14 |
| 3681 | LAMA4/PDGFB ratio | GCST90315273 | 1.14 |
| 3682 | NPY/SMOC1 ratio | GCST90315551 | 1.14 |
| 3683 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53 | ECGA000053 | 1.14 |
| 3684 | LAT2/SERPINB1 ratio | GCST90315279 | 1.13 |
| 3685 | SPARC/ZBTB16 ratio | GCST90315875 | 1.13 |
| 3686 | MNDA/NCF2 ratio | GCST90315472 | 1.13 |
| 3687 | Emphysema | FING00000496 | 1.13 |
| 3688 | Clonal haematopoiesis of indeterminate potential (TET2 mutation) | GCST90165281 | 1.13 |
| 3689 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T451 | ECGA000451 | 1.13 |
| 3690 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 1.13 |
| 3691 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T114 | ECGA000114 | 1.13 |
| 3692 | Pulmonary embolism | FING00001228 | 1.13 |
| 3693 | CD58/MEGF10 ratio | GCST90313853 | 1.13 |
| 3694 | HippSubfield lh volume presubiculum-head | GCST90002673 | 1.13 |
| 3695 | aparc-DKTatlas lh area postcentral | GCST90003254 | 1.13 |
| 3696 | AV-block | FING00000137 | 1.13 |
| 3697 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320930 | 1.13 |
| 3698 | Prevotellamassilia abundance in stool | GCST90032517 | 1.12 |
| 3699 | Operation code - spine or back surgery | Operations | UKBB00000565 | 1.12 |
| 3700 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87 | ECGA000087 | 1.12 |
| 3701 | Volume of left anterior amygdaloid area | GCST90474871 | 1.12 |
| 3702 | Mouth/teeth dental problems - Loose teeth | Mouth | UKBB00000487 | 1.12 |
| 3703 | EDIL3 levels | GCST90469072 | 1.12 |
| 3704 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25) | GCST90320588 | 1.12 |
| 3705 | OGFR levels | GCST90470118 | 1.12 |
| 3706 | Main speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000414 | 1.11 |
| 3707 | PTPN1/TDRKH ratio | GCST90315745 | 1.11 |
| 3708 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121 | ECGU000121 | 1.11 |
| 3709 | DTI TBSS MD Superior fronto-occipital fasciculus R | GCST90384614 | 1.11 |
| 3710 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450 | ECGU000450 | 1.11 |
| 3711 | Smoking/smokers in household | Smoking | UKBB00000783 | 1.11 |
| 3712 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T56 | ECGU000056 | 1.11 |
| 3713 | Blood urea nitrogen (BUN, maximum, inv-norm transformed) | GCST90475162 | 1.11 |
| 3714 | IDP T1 FAST ROIs L subcallosal cortex | GCST90002503 | 1.10 |
| 3715 | ICAM2/IL7R ratio | GCST90315117 | 1.10 |
| 3716 | MAVS/PPP1R9B ratio | GCST90315393 | 1.10 |
| 3717 | aparc-Desikan rh area TotalSurface | GCST90003107 | 1.10 |
| 3718 | TNFAIP2 levels | GCST90470896 | 1.10 |
| 3719 | aparc-a2009s rh volume G-cingul-Post-ventral | GCST90003008 | 1.10 |
| 3720 | FSTL1 levels | GCST90469271 | 1.10 |
| 3721 | Whole grain cereal liking | GCST90094869 | 1.10 |
| 3722 | Docosahexaenoic acid to total fatty acids percentage | GCST90501999 | 1.10 |
| 3723 | Right molecular layer hippocampal volume (body) | GCST90267975 | 1.10 |
| 3724 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43 | ECGA000043 | 1.10 |
| 3725 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T164 | ECGU000164 | 1.09 |
| 3726 | IDP T1 FAST ROIs R mid front gyrus | GCST90002458 | 1.09 |
| 3727 | TXN levels | GCST90470995 | 1.09 |
| 3728 | Polycystic ovarian syndrome | FING00001182 | 1.09 |
| 3729 | Cough on most days | Medical information | UKBB00000153 | 1.09 |
| 3730 | IDP dMRI ProbtrackX MD cst l | GCST90004227 | 1.09 |
| 3731 | aparc-Desikan lh thickness paracentral | GCST90003461 | 1.08 |
| 3732 | Unspecified osteomyelitis (PheCode 710.19) | GCST90476224 | 1.08 |
| 3733 | ISEI occupational score | GCST90446160 | 1.08 |
| 3734 | Docosahexaenoic acid levels | GCST90497252 | 1.08 |
| 3735 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7) | GCST90320570 | 1.08 |
| 3736 | IDP dMRI ProbtrackX L3 cgc l | GCST90004304 | 1.08 |
| 3737 | ERP29 levels | GCST90088843 | 1.07 |
| 3738 | Varicose veins of lower extremities | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000894 | 1.07 |
| 3739 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409 | ECGU000409 | 1.07 |
| 3740 | DTI autoptx L1 slf r tract | GCST90385161 | 1.07 |
| 3741 | MAP3K5/ZBTB16 ratio | GCST90315380 | 1.07 |
| 3742 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 1.07 |
| 3743 | Tyrosine levels | GCST90500156 | 1.07 |
| 3744 | MAVS/ZBTB16 ratio | GCST90315401 | 1.07 |
| 3745 | HSPG2 levels | GCST90179392 | 1.07 |
| 3746 | NEFL levels | GCST90470024 | 1.07 |
| 3747 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456 | ECGU000456 | 1.07 |
| 3748 | GBP6 levels | GCST90241368 | 1.06 |
| 3749 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175 | ECGU000175 | 1.06 |
| 3750 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1 | ECGA000001 | 1.06 |
| 3751 | IDP dMRI TBSS FA Splenium of corpus callosum | GCST90003881 | 1.06 |
| 3752 | CEP170 levels | GCST90468711 | 1.06 |
| 3753 | Docosahexaenoic acid levels | GCST90501986 | 1.06 |
| 3754 | EIF4G1/MAVS ratio | GCST90314636 | 1.06 |
| 3755 | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302700 | 1.06 |
| 3756 | SUMF1 levels | GCST90470783 | 1.06 |
| 3757 | Multi-trait sum score | GCST90270117 | 1.06 |
| 3758 | HippSubfield rh volume molecular-layer-HP-head | GCST90002699 | 1.05 |
| 3759 | C8 Carnitine levels in chronic kidney disease | GCST90257680 | 1.05 |
| 3760 | ENTPD5 levels | GCST90241024 | 1.05 |
| 3761 | Principal component-derived dietary pattern 27 | GCST90133032 | 1.05 |
| 3762 | ST13 levels | GCST90470751 | 1.05 |
| 3763 | Asthma | GCST90476024 | 1.05 |
| 3764 | Triacylglycerol_52:4_[M+NH4]1+ levels | GCST90060508 | 1.05 |
| 3765 | EDAR/SERPINB1 ratio | GCST90314586 | 1.05 |
| 3766 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 1.05 |
| 3767 | CDK8_CCNC levels | GCST90240825 | 1.05 |
| 3768 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 1.04 |
| 3769 | Non-HDL cholesterol levels | GCST90239669 | 1.04 |
| 3770 | NCS1/NPY ratio | GCST90315527 | 1.04 |
| 3771 | EDAR/IRAK4 ratio | GCST90314579 | 1.04 |
| 3772 | EHBP1 levels | GCST90469088 | 1.04 |
| 3773 | Frailty (General Factor) | GCST90624046 | 1.04 |
| 3774 | Hearing difficulty/problems: No (UKB data field 2247_0) | GCST90042881 | 1.04 |
| 3775 | FADD/MGLL ratio | GCST90314768 | 1.04 |
| 3776 | IDP dMRI TBSS L2 Posterior thalamic radiation R | GCST90004151 | 1.03 |
| 3777 | IDP dMRI TBSS ICVF Body of corpus callosum | GCST90004330 | 1.03 |
| 3778 | IDP dMRI TBSS L2 Posterior thalamic radiation L | GCST90004152 | 1.03 |
| 3779 | Open bite | FING00000903 | 1.03 |
| 3780 | PFKM levels | GCST90618802 | 1.03 |
| 3781 | wg lh intensity-contrast paracentral | GCST90003808 | 1.03 |
| 3782 | Sensorineural hearing loss (PheCode 389.1) | GCST90475911 | 1.03 |
| 3783 | LTA levels | GCST90469813 | 1.03 |
| 3784 | CXCL3/CXCL5 ratio | GCST90314344 | 1.03 |
| 3785 | Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systems | UKBB00000625 | 1.03 |
| 3786 | IL18R1 levels | GCST90241607 | 1.03 |
| 3787 | Biliary atresia | GCST90296484 | 1.03 |
| 3788 | SMAD1/ZBTB16 ratio | GCST90315853 | 1.03 |
| 3789 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T353 | ECGA000353 | 1.03 |
| 3790 | SCG3 levels | GCST90470539 | 1.03 |
| 3791 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T356 | ECGA000356 | 1.02 |
| 3792 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165 | ECGA000165 | 1.02 |
| 3793 | MOCS2 levels | GCST90469928 | 1.02 |
| 3794 | aparc-pial rh area precentral | GCST90003197 | 1.02 |
| 3795 | IDP dMRI TBSS FA Body of corpus callosum | GCST90003880 | 1.02 |
| 3796 | ABHD14B/SPARC ratio | GCST90313146 | 1.02 |
| 3797 | Tryptophan levels | GCST90243403 | 1.02 |
| 3798 | DPP4 levels | GCST90469033 | 1.02 |
| 3799 | FGR levels | GCST90469236 | 1.02 |
| 3800 | Benign neoplasm: salivary glands, exclude unknown (D119) | FING00000199 | 1.02 |
| 3801 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19 | ECGA000019 | 1.02 |
| 3802 | MERTK levels | GCST90469890 | 1.02 |
| 3803 | Calculus of lower urinary tract | FING00000237 | 1.02 |
| 3804 | Collagenous colitis | GCST90204145 | 1.02 |
| 3805 | Cardiomyopathy (PheCode 425) | GCST90475949 | 1.02 |
| 3806 | IDP dMRI TBSS ICVF Genu of corpus callosum | GCST90004329 | 1.02 |
| 3807 | Iron deficiency anaemia | FING00000699 | 1.01 |
| 3808 | DTI autoptx L3 cgc r tract | GCST90385198 | 1.01 |
| 3809 | DTI autoptx FA unc r tract | GCST90385138 | 1.01 |
| 3810 | IL6ST/TYRO3 ratio | GCST90315170 | 1.01 |
| 3811 | CAG-269 sp001915995 abundance in stool | GCST90032266 | 1.01 |
| 3812 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453 | ECGU000453 | 1.01 |
| 3813 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23 | ECGA000023 | 1.01 |
| 3814 | Takes medication for asthma? | GCST90475260 | 1.01 |
| 3815 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122 | ECGU000122 | 1.01 |
| 3816 | Cataract (PheCode 366) | GCST90043785 | 1.01 |
| 3817 | IDP T1 FAST ROIs R planum temporale | GCST90002542 | 1.01 |
| 3818 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82 | ECGA000082 | 1.01 |
| 3819 | ITGB1 levels | GCST90469643 | 1.00 |
| 3820 | Other and unspecified iron deficiency | FING00000940 | 1.00 |
| 3821 | ITPR1 levels | GCST90469655 | 1.00 |
| 3822 | Rotator cuff syndrome | FING00001270 | 1.00 |
| 3823 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 1.00 |
| 3824 | STAT2 levels | GCST90470758 | 1.00 |
| 3825 | F-lentils/beans liking (derived food-liking factor) | GCST90094793 | 1.00 |
| 3826 | Pain (PheCode 338) | GCST90475836 | 1.00 |
| 3827 | IDP dMRI TBSS FA Retrolenticular part of internal capsule R | GCST90003897 | 1.00 |
| 3828 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668739 | 1.00 |
| 3829 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226 | ECGU000226 | 1.00 |
| 3830 | CD4/LILRB4 ratio | GCST90313843 | 1.00 |
| 3831 | ALB levels | GCST90475106 | 1.00 |
| 3832 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T129 | ECGU000129 | 1.00 |
| 3833 | magnesium (Mg, maximum, inv-norm transformed) | GCST90475477 | 1.00 |
| 3834 | ESAM/JAM2 ratio | GCST90314712 | 1.00 |
| 3835 | T1 FreeSurfer BA lh BA2 exvivo volume | GCST90385534 | 1.00 |
| 3836 | NAAA levels | GCST90469991 | 1.00 |
| 3837 | ThalamNuclei lh volume PuI | GCST90002714 | 1.00 |
| 3838 | Ulcerative colitis | GCST90468152 | 1.00 |
| 3839 | T1 FreeSurfer aseg rhCerebralWhiteMatterVol | GCST90384186 | 0.99 |
| 3840 | IDP dMRI ProbtrackX OD ilf r | GCST90004465 | 0.99 |
| 3841 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T357 | ECGA000357 | 0.99 |
| 3842 | IDP dMRI TBSS L2 Body of corpus callosum | GCST90004126 | 0.99 |
| 3843 | Mixed conductive and sensorineural hearing loss | FING00000827 | 0.99 |
| 3844 | UROD levels | GCST90471016 | 0.99 |
| 3845 | CCL15 levels | GCST90468567 | 0.99 |
| 3846 | IDP dMRI ProbtrackX ICVF ilf r | GCST90004390 | 0.99 |
| 3847 | Other disorders of urethra and urinary system | FING00001039 | 0.99 |
| 3848 | Skin color (cheek, B value) | GCST90502779 | 0.99 |
| 3849 | IDP T1 FAST ROIs V cerebellum VIIIa | GCST90002579 | 0.99 |
| 3850 | HDAC8 levels | GCST90469438 | 0.98 |
| 3851 | Weight | GCST90018729 | 0.98 |
| 3852 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392 | ECGA000392 | 0.98 |
| 3853 | GFRA1/TNFRSF1A ratio | GCST90314924 | 0.98 |
| 3854 | CNTN4 levels | GCST90468806 | 0.98 |
| 3855 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460 | ECGU000460 | 0.98 |
| 3856 | PLXNA4/SRPK2 ratio | GCST90315688 | 0.98 |
| 3857 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424 | ECGU000424 | 0.98 |
| 3858 | Cataracts | GCST90475382 | 0.98 |
| 3859 | PRL levels | GCST90470332 | 0.98 |
| 3860 | Fasting insulin | GCST90002238 | 0.97 |
| 3861 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166 | ECGU000166 | 0.97 |
| 3862 | NSFL1C levels | GCST90470089 | 0.97 |
| 3863 | Blood urea nitrogen (BUN, mean, inv-norm transformed) | GCST90475165 | 0.97 |
| 3864 | YAP1 levels | GCST90471086 | 0.97 |
| 3865 | F11R/PARK7 ratio | GCST90314723 | 0.97 |
| 3866 | DTI TBSS L2 Superior longitudinal fasciculus R | GCST90384516 | 0.97 |
| 3867 | Main speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000417 | 0.97 |
| 3868 | RRAS levels | GCST90470499 | 0.97 |
| 3869 | Platelet count during first trimester of pregnancy | GCST90302224 | 0.97 |
| 3870 | Bicarbonate (maximum, inv-norm transformed) | GCST90475145 | 0.96 |
| 3871 | GAL/PM20D1 ratio | GCST90314917 | 0.96 |
| 3872 | Left-hemisphere default mode network to putamen white-matter structural connectivity | GCST90302769 | 0.96 |
| 3873 | CNTN3/FETUB ratio | GCST90314164 | 0.96 |
| 3874 | MMP12 levels | GCST90012070 | 0.96 |
| 3875 | Hearing difficulty/problems: Yes (UKB data field 2247_1) | GCST90042882 | 0.96 |
| 3876 | CNTN4 levels | GCST90240786 | 0.96 |
| 3877 | Excessive hairiness | GCST006095 | 0.96 |
| 3878 | MAVS levels | GCST90469866 | 0.96 |
| 3879 | aparc-Desikan lh volume parstriangularis | GCST90002787 | 0.96 |
| 3880 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22 | ECGA000022 | 0.96 |
| 3881 | ESR1 levels | GCST90469155 | 0.96 |
| 3882 | Urea levels (UKB data field 30670) | GCST90468108 | 0.96 |
| 3883 | Prescriptions - paracetamol | antipyretic | UKBB00000696 | 0.96 |
| 3884 | Prescriptions - antipyretic | UKBB00000665 | 0.96 |
| 3885 | wg rh intensity-contrast inferiorparietal | GCST90003834 | 0.95 |
| 3886 | aparc-DKTatlas lh area pericalcarine | GCST90003253 | 0.95 |
| 3887 | Capers liking | GCST90094724 | 0.95 |
| 3888 | aparc-pial lh area precentral | GCST90003164 | 0.95 |
| 3889 | DKK1/ZBTB16 ratio | GCST90314486 | 0.95 |
| 3890 | BA-exvivo rh volume V2 | GCST90002859 | 0.95 |
| 3891 | Triacylglycerol_52:6_[M+NH4]1+ levels | GCST90060504 | 0.95 |
| 3892 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 0.95 |
| 3893 | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | FING00000431 | 0.95 |
| 3894 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 0.95 |
| 3895 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228 | ECGU000228 | 0.95 |
| 3896 | FCER2/TNFRSF9 ratio | GCST90314791 | 0.95 |
| 3897 | Irritability | Mental health | UKBB00000380 | 0.94 |
| 3898 | MYDGF levels | GCST90469972 | 0.94 |
| 3899 | DOK2/FADD ratio | GCST90314530 | 0.94 |
| 3900 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T123 | ECGU000123 | 0.94 |
| 3901 | ALB levels | GCST90025992 | 0.94 |
| 3902 | Secondary hypertension | FING00001285 | 0.94 |
| 3903 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T89 | ECGA000089 | 0.94 |
| 3904 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132 | ECGU000132 | 0.94 |
| 3905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66 | ECGU000066 | 0.94 |
| 3906 | CGA levels | GCST90468732 | 0.94 |
| 3907 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 0.94 |
| 3908 | aparc-Desikan lh area pericalcarine | GCST90003093 | 0.94 |
| 3909 | HPGDS/ITGAV ratio | GCST90315080 | 0.94 |
| 3910 | DSC2/EFEMP1 ratio | GCST90314555 | 0.94 |
| 3911 | EDAR/TMSB10 ratio | GCST90314590 | 0.94 |
| 3912 | PTPRH levels | GCST90470382 | 0.93 |
| 3913 | A4GALT levels | GCST90427457 | 0.93 |
| 3914 | ThalamNuclei lh volume VLp | GCST90002734 | 0.93 |
| 3915 | NRSN1 levels | GCST90242062 | 0.93 |
| 3916 | Acquired foot deformities (PheCode 735) | GCST90476247 | 0.93 |
| 3917 | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302806 | 0.93 |
| 3918 | Hippocampal subfield left CA4 volume (head) | GCST90267943 | 0.93 |
| 3919 | rfMRI amplitudes (ICA100 node 30) | GCST90004618 | 0.93 |
| 3920 | aseg rh intensity Putamen | GCST90003784 | 0.93 |
| 3921 | PGR levels | GCST90470223 | 0.93 |
| 3922 | Flat foot [pes planus] (acquired) | FING00000545 | 0.93 |
| 3923 | PSMD9/UBAC1 ratio | GCST90315735 | 0.92 |
| 3924 | MUC13 levels | GCST90469963 | 0.92 |
| 3925 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 0.92 |
| 3926 | Left ventricular end systole anterior wall thickness | GCST90278512 | 0.92 |
| 3927 | AXIN1/INPPL1 ratio | GCST90313410 | 0.92 |
| 3928 | DTI autoptx L1 ilf r tract | GCST90385154 | 0.92 |
| 3929 | KDR levels | GCST90469672 | 0.92 |
| 3930 | Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels | GCST90200013 | 0.92 |
| 3931 | CALCOCO1/CASP8 ratio | GCST90313597 | 0.92 |
| 3932 | Cylindrical power (right) | Autorefraction | UKBB00000162 | 0.92 |
| 3933 | Volume of left cortical nucleus | GCST90474886 | 0.92 |
| 3934 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3 | ECGA000003 | 0.92 |
| 3935 | Massiliomicrobiota abundance in stool | GCST90032470 | 0.92 |
| 3936 | Otitis externa | FING00001128 | 0.91 |
| 3937 | MVK/SERPINE1 ratio | GCST90315505 | 0.91 |
| 3938 | FGFR2/TGFBR2 ratio | GCST90314813 | 0.91 |
| 3939 | aparc-Desikan lh volume postcentral | GCST90002789 | 0.91 |
| 3940 | SCARA5/TNC ratio | GCST90315810 | 0.91 |
| 3941 | Serum creatinine levels | GCST90018759 | 0.91 |
| 3942 | CREG1/SMPDL3A ratio | GCST90314252 | 0.91 |
| 3943 | IDP dMRI TBSS ICVF Uncinate fasciculus R | GCST90004371 | 0.91 |
| 3944 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 0.91 |
| 3945 | Other non-toxic goitre | Disorders of thyroid gland | UKBB00000617 | 0.91 |
| 3946 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461 | ECGU000461 | 0.91 |
| 3947 | PTX3 levels | GCST90470392 | 0.91 |
| 3948 | SERPINF1 levels | GCST90470598 | 0.91 |
| 3949 | ADH4/KRT18 ratio | GCST90313192 | 0.91 |
| 3950 | GOLGA3 levels | GCST90469375 | 0.91 |
| 3951 | VCAM1 levels | GCST90243317 | 0.91 |
| 3952 | BA-exvivo lh volume BA1 | GCST90002835 | 0.91 |
| 3953 | BA-exvivo lh area BA2 | GCST90003208 | 0.91 |
| 3954 | F-sharp flavour liking (derived food-liking factor) | GCST90094837 | 0.91 |
| 3955 | LTBR/TNFRSF14 ratio | GCST90315340 | 0.91 |
| 3956 | DTI TBSS L1 Body of corpus callosum | GCST90384431 | 0.90 |
| 3957 | TXNL1 levels | GCST90470993 | 0.90 |
| 3958 | GBP4 levels | GCST90469313 | 0.90 |
| 3959 | SUSD4 levels | GCST90470788 | 0.90 |
| 3960 | NRCAM/NTRK2 ratio | GCST90315552 | 0.90 |
| 3961 | Other diseases of intestine | Other diseases of intestines | UKBB00000605 | 0.90 |
| 3962 | DECR1/METAP1D ratio | GCST90314448 | 0.90 |
| 3963 | SF3B4 levels | GCST90470609 | 0.90 |
| 3964 | BCAN/DPP6 ratio | GCST90313478 | 0.90 |
| 3965 | RECK levels | GCST90470445 | 0.90 |
| 3966 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320822 | 0.90 |
| 3967 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116 | ECGU000116 | 0.90 |
| 3968 | Sleep apnea (MTAG) (adjusted for BMI) | GCST90267364 | 0.90 |
| 3969 | Asthma | GCST006862 | 0.90 |
| 3970 | Type 1 diabetes | GCST90018705 | 0.89 |
| 3971 | Pregnenetriol disulfate levels | GCST90200238 | 0.89 |
| 3972 | TNFSF10 levels | GCST90012011 | 0.89 |
| 3973 | HippSubfield lh volume subiculum-head | GCST90002671 | 0.89 |
| 3974 | COL3A1 levels | GCST90468817 | 0.89 |
| 3975 | Other peripheral vertigo | FING00001088 | 0.89 |
| 3976 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T355 | ECGA000355 | 0.89 |
| 3977 | MFAP5 levels | GCST90469899 | 0.89 |
| 3978 | PPCDC levels | GCST90470290 | 0.89 |
| 3979 | Colorectal cancer (PheCode 153) | GCST90475566 | 0.89 |
| 3980 | CCL19 levels | GCST90274765 | 0.89 |
| 3981 | NCAN levels | GCST90470005 | 0.89 |
| 3982 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 0.89 |
| 3983 | Abdominal aortic calcification levels | GCST90134614 | 0.88 |
| 3984 | PILRA/TNFRSF1A ratio | GCST90315655 | 0.88 |
| 3985 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502415 | 0.88 |
| 3986 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T65 | ECGU000065 | 0.88 |
| 3987 | Ceramide (d18:2/22:0) levels | GCST90024682 | 0.88 |
| 3988 | LGMN/SPINT2 ratio | GCST90315324 | 0.88 |
| 3989 | Liver volume (adjusted for height) | GCST90566819 | 0.88 |
| 3990 | SPINK6 levels | GCST90470725 | 0.88 |
| 3991 | Lactate levels | GCST90092882 | 0.87 |
| 3992 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T44 | ECGA000044 | 0.87 |
| 3993 | LAG3/VCAM1 ratio | GCST90315270 | 0.87 |
| 3994 | Prescriptions - anti-malarial | UKBB00000663 | 0.87 |
| 3995 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 0.87 |
| 3996 | RGMB levels | GCST90470464 | 0.87 |
| 3997 | Left-hemisphere visual network to left-hemisphere limbic network white-matter structural connectivity | GCST90302652 | 0.87 |
| 3998 | N-acetyl-2-aminoadipate levels | GCST90200268 | 0.87 |
| 3999 | CPPED1 levels | GCST90468845 | 0.87 |
| 4000 | Other retinal disorders | FING00001094 | 0.87 |